-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631.O2.6 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Stem Cell Biology in Myeloproliferative Syndromes

Symposia: Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, CHIP, MPN, Translational Research, Hematopoiesis, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Myeloid Malignancies, Biological Processes, Molecular biology, Pathogenesis
Monday, December 9, 2024: 10:30 AM-12:00 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Fan He, PhD, Washington University School of Medicine and Ami Patel, MD, Huntsman Cancer Institute, University of Utah
Disclosures:
Patel: Genentech, Menarini Stemline: Honoraria, Research Funding.
10:30 AM

Quentin Kimmerlin1*, Marc Usart1*, Tiago Fonseca1*, Hui Hao-Shen2* and Radek C. Skoda, MD1

1Experimental Hematology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland
2Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland

10:45 AM

Camelia Benlabiod, PhD1*, Gurvan Hermange, PhD2*, Laetitia Borderon1*, Quentin Blampey2*, Maxime Evrard1*, Antonio Rodriguez Romera3*, Stéphanie G. Moreno4*, Nathalie Gault4*, Philippe Rameau5*, Cyril Catelain5*, Elodie Rosa1*, Bethan Psaila, MD, PhD6,7, Claus Nerlov, PhD8*, Sten Eirik Waelgaard Jacobsen, MD, PhD9,10*, William Vainchenker, MD, PhD1*, Hana Raslova, PhD1*, Paul-Henry Cournède, PhD2*, Isabelle Plo, PhD1* and Caroline Marty, PhD1*

1INSERM UMR1287, Gustave Roussy, Paris-Saclay University, Villejuif, France
2Laboratory of Applied Mathematics and Computer Sciences (MICS), Université Paris-Saclay, CentraleSupélec, Gif-sur-Yvette, France
3Medical Research Council Weatherall Institute of Molecular Medicine (MRC WIMM) and NIHR Biomedical Research Centre Hematology Theme, University of Oxford, Oxford, ENG, United Kingdom
4INSERM UMR1274, CEA - DRF/ IBFJ/ iRCM/ LSHL, Fontenay-aux-Roses, France
5UMS AMMICa-Plateforme Imagerie et Cytométries, Gustave Roussy, Villejuif, FRA
6Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, ENG, United Kingdom
7Oxford University Hospitals NHS Trust, Oxford, United Kingdom
8MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
9Center for Hematology and Regenerative Medicine (HERM) - Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
10MRC Molecular Haematology Unit - MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

11:00 AM

Ian Ghezzi1,2*, Sercan Öz1*, Istiffa Nurfauziah1*, Sena Alptekin, MD1,2*, Esther Rodriguez-Correa, PhD1,2*, Lena Bognar1,2*, Foteini Fotopoulou, PhD1,2* and Michael D. Milsom, PhD3,4

1German Cancer Research Center (DKFZ), Heidelberg, Germany
2HI-STEM Ggmbh, Heidelberg, Germany
3HI-STEM Ggmbh, Heidelberg, DEU
4Division of Experimental Hematology, DKFZ, Heidelberg, Germary, Heidelberg, DEU

11:15 AM

Dennis M Bonal, MSc, BSc1,2,3, Anna Dorota Chorzalska, PhD4,5,6*, Alissa Oakes, PhD6,7*, Makayla R Pardo8, Seo-Ho Lee4,9*, Michael Y Clarke6*, Max Petersen6*, Hyunju Oh, BS5*, Valeria Brown6*, Diana Olguta Treaba, MD10*, John L. Reagan, MD1,11,12,13, Adam J. Olszewski, MD6,14,15, Mark Dooner16*, John Morgan, PhD4*, Joslyn Mills, PhD17*, Paul Bertone, PhD3,7* and Patrycja M Dubielecka, PhD3,7,8,18

1Legorreta Cancer Center, Brown University, Providence, RI
2Pathobiology Graduate Program, Brown University, Douglas, MA
3Warren Alpert Medical School of Brown University, Providence, RI
4Dubielecka Lab, Rhode Island Hospital, Providence, RI
5Warren Alpert Medical School, Brown University, Providence, RI
6Brown University, Providence, RI
7Legorreta Cancer Center of Brown University, Providence, RI
8Pathobiology Graduate Program, Brown University, Providence, RI
9Legorreta Cancer Center, Brown University, Amherst, MA
10Rhode Island Hospital, Department of Pathology and Laboratory Medicine, Providence, RI
11Brown University Health Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
12Brown University Health Cancer Insitute, Warren Alpert Medical School of Brown University, Providence, RI
13Brown University Health Cancer Institute, Brown University Health, Providence, RI
14Brown Univeristy, Providence, RI
15Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI
16Lifespan Cancer Institute Providence, Providence
17Biology Department, Bridgewater State University, Bridgewater, MA
18Rhode Island Hospital and Warren Alpert Medical School At Brown University, Providence, RI

11:30 AM

Tyler M Parsons, PhD1, Aishwarya Krishnan, MS1, Andrew L Young, MD, PhD2, Maggie Cox3*, Stephen Oh, MD, PhD4 and Grant A Challen, PhD5

1Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
2Division of Hematology, Washington University School of Medicine in St. Louis, St. Louis, MO
3Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO
4Washington University School of Medicine, Saint Louis, MO
5Division of Oncology, Washington University School of Medicine, St. Louis, MO

11:45 AM

Linda Resar, MD1, Joseph Kim2,3, Audrey-Ann Supreme, BS4,5*, Hyunsung Woo, MS6*, Bailey West, BS7*, Mariah C. Antopia, BS8*, Zanshe Thompson, PhD, MS9, Karen Reddy, PhD10*, Jung-Hyun Kim, PhD10*, Leslie Cope, PhD2*, Raajit Rampal, MD, PhD11, Richard Koche, PhD12,13*, Alison R. Moliterno, MD14 and Jerry L. Spivak, MD15

1Division of Hematology, Departments of Medicine, Oncology & Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD
2Johns Hopkins University School of Medicine, Baltimore, MD
3Cellular and Molecular Medicine Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD
4Doctoral Diversity Program, Johns Hopkins University School of Medicine, Baltimore, MD
5Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
6Whiting School of Engineering, The Johns Hopkins University, Baltimore, MD
7Pathobiology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD
8The Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
9Division of Hematology, The Johns Hopkins University School of Medicine, Owings Mills, MD
10The Johns Hopkins University School of Medicine, Baltimore, MD
11Memorial Sloan Kettering Cancer Center, New York, NY
12Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY
13Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Center for Epigenetics, Memorial Sloan Kettering Cancer Center, New York, NY
14Division of Hematology, Department of Medicine, Johns Hopkins University/Fda, Silver Spring, MD
15Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

*signifies non-member of ASH